101 reports of this reaction
2.7% of all VECURONIUM BROMIDE reports
#6 most reported adverse reaction
UNEVALUABLE EVENT is the #6 most commonly reported adverse reaction for VECURONIUM BROMIDE, manufactured by Eugia US LLC. There are 101 FDA adverse event reports linking VECURONIUM BROMIDE to UNEVALUABLE EVENT. This represents approximately 2.7% of all 3,750 adverse event reports for this drug.
Patients taking VECURONIUM BROMIDE who experience unevaluable event should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
UNEVALUABLE EVENT is a less commonly reported adverse event for VECURONIUM BROMIDE, but still significant enough to appear in the safety profile.
In addition to unevaluable event, the following adverse reactions have been reported for VECURONIUM BROMIDE:
The following drugs have also been linked to unevaluable event in FDA adverse event reports:
UNEVALUABLE EVENT has been reported as an adverse event in 101 FDA reports for VECURONIUM BROMIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
UNEVALUABLE EVENT accounts for approximately 2.7% of all adverse event reports for VECURONIUM BROMIDE, making it a notable side effect.
If you experience unevaluable event while taking VECURONIUM BROMIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.